Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1139774

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1139774

Hydrocolloid Dressing Market Size - By Raw Material, By Application, By Product, By End-User - Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

PUBLISHED:
PAGES: 256 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Group License)
USD 5650
PDF (Company License)
USD 7450

Add to Cart

According to SPER Market Research, the Hydrocolloid Dressing Market estimated to reach USD 2.12 billion by 2030 with a CAGR of 5.5%.

Accidents frequently cause severe bleeding and other injuries, demanding immediate medical attention and surgical procedures to provide patients with relief right away. Because hydrocolloid dressings are efficient for both acute and chronic wounds of various thicknesses, the prevalence of both chronic and acute wounds is thus anticipated to increase.

In lower discharge or necrotic tissue, they promote autolytic debridement. For the treatment of pressure injuries, they adhere successfully to high-friction regions such as the heels and the sacrum. In order to reduce pressure injuries caused by medical devices, hydrocolloid dressings are also used as protective dressings on intubated patients in the ICU. Abrasions and small burns are also treated with them. The aforementioned factors are hence driving the expansion of the hydrocolloid dressing market. Due to its absorbency and ability to provide a barrier of protection over the skin, hydrocolloid technology has long been used in advanced wound care.

The use of additives and recent breakthroughs in hydrocolloid technology has considerably improved patient care. The production of materials using contemporary hydrocolloid extruders is more efficient, reliable, and waste-free. The creation of hybrid materials that mix hydrocolloid and acrylic PSA is another development in the hydrocolloid family. One such development is the exclusive Thin Absorbent Skin Adhesive from Avery Dennison Medical (TASA).

A variety of carrier materials, including polyurethane films and nonwovens, can be coated with adhesive. Standard hydrocolloid adhesives typically range in thickness from 0.3 to 1.0 mm, but TASA is only 0.1 mm thick. Additionally, it encourages absorbency and breathability. Wear periods of up to seven days are possible because of these exceptional fluid-handling characteristics. As a result, these improvements and advancements have created a wide range of new opportunities for a better patient experience, boosting the industry. Using a hydrocolloid dressing for advanced wound care has a number of additional benefits, such as high durability, quicker healing, reduced discomfort, a lower risk of infection, and adherence exclusively to surrounding skin. In addition, hydrocolloids are inexpensive, versatile, and waterproof. When wounds are partially healed or newly healed skin is still intact, they can make an excellent protective barrier to shield the area from potential surface harm. Because of the mentioned advantages offered by hydrocolloid dressings, their use is therefore expected to increase during the projection period.

Impact of COVID-19 on the Global Hydrocolloid Dressing Market:

Doctors and other front-line personnel have greatly benefited from the hydrocolloid dressing's ability to avoid facial pressure and facial markings when wearing medical protective equipment during the COVID-19 epidemic. A layer of semi-permeable hydrocolloid, commonly used for wound healing, can be found inside a film or foam pad that clings to the skin. This is accomplished by using a hydrocolloid dressing. Following the trimming of the hydrocolloid dressing, the adhesive dressing is applied to the skin of the nasal dorsum, cheeks, and forehead, covering the region where the mask and safety goggles would sit. This has a substantial impact on the market expansion of hydrocolloids in the pharmaceutical industry.

Scope of the report

Report Metric Details:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030
  • Segments covered: By Raw Material, By Application, By Product, By End-User
  • Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
  • Companies Covered: B. Braun Melsungen AG, Cardinal Health, Convatec Inc., Covalon Technologies Ltd., Coloplast Corp., Dermarite Industries LLC., Johnson & Johnson, Lohmann & Rauscher, Medline Industries Inc., Paul Hartmann AG, Smith & Nephew, 3M.

Global Hydrocolloid Dressing Market, By Raw Material:

Based on the Raw Material, Global Hydrocolloid Dressing Market is segmented as; Synthetic, Natural, Semi-Synthetic.

Global Hydrocolloid Dressing Market, By Application:

Based on the Application, Global Hydrocolloid Dressing Market is segmented as; Pressure Ulcer, Venous leg Ulcer, Diabetic Ulcer, Burn Wounds, Others.

Global Hydrocolloid Dressing Market, By Product:

Based on the Product, Global Hydrocolloid Dressing Market is segmented as; Sheet Dressings, Amorphous, Impregnated Dressings.

Global Hydrocolloid Dressing Market, By End-User:

Based on the End-User, Global Hydrocolloid Dressing Market is segmented as; Homecare Settings, Hospitals & Clinics, Others.

Global Hydrocolloid Dressing Market, By Regions:

The Global Hydrocolloid Dressing Market is majorly driven by North-America. During the projected period, North-America is anticipated to have the quickest rate of growth in the worldwide Hydrocolloid Dressing Market.

Product Code: HLCA2211

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Hydrocolloid Dressing Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Hydrocolloid Dressing Market , By Raw Material, 2019-2030 (USD Million)

  • 6.1. Synthetic
  • 6.2. Natural
  • 6.3. Semi-Synthetic

7. Global Hydrocolloid Dressing Market , By Application, 2019-2030 (USD Million)

  • 7.1. Pressure Ulcer
  • 7.2. Venous leg Ulcer
  • 7.3. Diabetic Ulcer
  • 7.4. Burn Wounds
  • 7.5. Others

8. Global Hydrocolloid Dressing Market , By Product, 2019-2030 (USD Million)

  • 8.1. Sheet Dressings
  • 8.2. Amorphous
  • 8.3. Impregnated Dressings

9. Global Hydrocolloid Dressing Market , By End-User, 2019-2030 (USD Million)

  • 9.1. Homecare Settings
  • 9.2. Hospitals & Clinics
  • 9.3. Others

10. Global Hydrocolloid Dressing Market , By Region , 2019-2030 (USD Million)

  • 10.1. North America
    • 10.1.1. United States
    • 10.1.2. Canada
    • 10.1.3. Mexico
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. United Kingdom
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. South Korea
    • 10.3.6. Rest of Asia-Pacific
  • 10.4. South America
    • 10.4.1. Brazil
    • 10.4.2. Argentina
    • 10.4.3. Rest of South America
  • 10.5. Middle East & Africa
    • 10.5.1. Kingdom of Saudi Arabia
    • 10.5.2. United Arab Emirates
    • 10.5.3. Rest of Middle East & Africa

11. Company Profiles

  • 11.1. B. Braun Melsungen AG
    • 11.1.1. Company details
    • 11.1.2. Financial outlook
    • 11.1.3. Product summary
    • 11.1.4. Recent developments
  • 11.2. Cardinal Health
    • 11.2.1. Company details
    • 11.2.2. Financial outlook
    • 11.2.3. Product summary
    • 11.2.4. Recent developments
  • 11.3. Convatec Inc.
    • 11.3.1. Company details
    • 11.3.2. Financial outlook
    • 11.3.3. Product summary
    • 11.3.4. Recent developments
  • 11.4. Covalon Technologies Ltd.
    • 11.4.1. Company details
    • 11.4.2. Financial outlook
    • 11.4.3. Product summary
    • 11.4.4. Recent developments
  • 11.5. Coloplast Corp.
    • 11.5.1. Company details
    • 11.5.2. Financial outlook
    • 11.5.3. Product summary
    • 11.5.4. Recent developments
  • 11.6. Dermarite Industries LLC.
    • 11.6.1. Company details
    • 11.6.2. Financial outlook
    • 11.6.3. Product summary
    • 11.6.4. Recent developments
  • 11.7. Johnson & Johnson
    • 11.7.1. Company details
    • 11.7.2. Financial outlook
    • 11.7.3. Product summary
    • 11.7.4. Recent developments
  • 11.8. Lohmann & Rauscher
    • 11.8.1. Company details
    • 11.8.2. Financial outlook
    • 11.8.3. Product summary
    • 11.8.4. Recent developments
  • 11.9. Medline Industries Inc.
    • 11.9.1. Company details
    • 11.9.2. Financial outlook
    • 11.9.3. Product summary
    • 11.9.4. Recent developments
  • 11.10. Paul Hartmann AG
    • 11.10.1. Company details
    • 11.10.2. Financial outlook
    • 11.10.3. Product summary
    • 11.10.4. Recent developments
  • 11.11. Smith & Nephew
    • 11.11.1. Company details
    • 11.11.2. Financial outlook
    • 11.11.3. Product summary
    • 11.11.4. Recent developments
  • 11.12. 3M
    • 11.12.1. Company details
    • 11.12.2. Financial outlook
    • 11.12.3. Product summary
    • 11.12.4. Recent developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!